BioWorld - Wednesday, May 6, 2026

BioWorld Science

Feb. 22, 2022

View Archived Issues

LCDR regulates lysosomal function through stabilization of LAPTM5 and promotes cancer cell survival

Read More

CC40.8 antibody confers protection against SARS-CoV-2 infection

Read More

New curcumin derivatives show activity against non-small lung cancer

Read More

Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists

Read More

Betta Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

Read More

Discovery of KP-1, an antifibrotic peptide that ameliorates renal fibrosis in vivo

Read More

Chinese investigators identify Toll-like receptor antagonists

Read More

Apotex patents new antiviral compounds

Read More

Shaanxi Synthetic Pharmaceutical presents new thiobenzopyran compounds

Read More

Novel Hsp90/HDAC dual inhibitor shows antifungal activity against azole-resistant Candida albicans

Read More

RosVivo signs material transfer agreement with Lilly for RSVI-301 for diabetes

Read More

Researchers present in vitro data for GYS1 inhibitor MZE-001 in Pompe disease

Read More

APTA-1 shows promising biological effects in a coronavirus-induced acute lung injury model

Read More

Grant supports Emergex's development of synthetic T-cell vaccine candidate for Chikungunya virus

Read More

BioNTech and Medigene collaborate to develop TCR-based immunotherapies for cancer

Read More

NovoBiome and Inserm collaborate on intestinal organoid-on-a-chip technology

Read More

Engineered Wnt ligands repair BBB in neuro disorders

Read More